Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ecc0509
Metabolic Dysfunction-Associated Steatohepatitis
Eccogene
P2
B
(60)
Efinopegdutide
Metabolic Dysfunction-Associated Steatotic Liver Disease
Merck Sharp & Dohme LLC
P2
B
(60)
Enasidenib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P2
B
(60)
Enasidenib
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P2
B
(60)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Cancer
Astellas Pharma Global Development, Inc.
P2
B
(60)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Urethra Cancer
Emory University
P2
B
(60)
Entinostat
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Entrectinib
Sarcoma
OHSU Knight Cancer Institute
P2
B
(60)
Envafolimab
Renal Cell Carcinoma
Peking Union Medical College Hospital
P2
B
(60)
Enzalutamide
Head And Neck Squamous Cell Carcinoma
MacroGenics
P2
B
(60)
Epcoritamab
Primary Central Nervous System Lymphoma
The Lymphoma Academic Research Organisation
P2
B
(60)
Epcoritamab
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical Center
P2
B
(60)
Epirubicin
Childhood Malignant Neoplasm
Children's Hospital Medical Center, Cincinnati
P2
B
(60)
Epirubicin
Liver Cancer
Tang-Du Hospital
P2
B
(60)
Etoposide
Adenosquamous Lung Carcinoma
Barbara Ann Karmanos Cancer Institute
P2
B
(60)
Etoposide
Astrocytic Tumor
Oliver Jonas
P2
B
(60)
Etoposide
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto
P2
B
(60)
Etoposide
Ependymoma
Theodore S. Johnson
P2
B
(60)
Etoposide
Medulloblastoma
Theodore S. Johnson
P2
B
(60)
Etoposide
Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Etoposide
Neoplasm
Shanghai Pulmonary Hospital, Shanghai, China
P2
B
(60)
Everolimus
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
B
(60)
Fludarabine
Acute Leukemia Of Ambiguous Lineage
Janssen Research & Development, LLC
P2
B
(60)
Fludarabine
Anal Carcinoma
Christian Hinrichs
P2
B
(60)
Showing 1776 to 1800 of 13,155 assets
Previous
Page 72 of 527
Next